Pharmidex is pleased to announce that Ian Knowles and Janette Dalay Robertson , will be attending TARGET TO PATIENT 2026 (T2P26) on Monday 20th – Tuesday 21st April 2026 at the Hinxton Hall Conference Centre, Wellcome Genome Campus, Cambridge, UK. They look forward to meeting founders, investors and biotech leaders to discuss drug discovery, translational partnerships and life science investment opportunities. Feel free to catch them for a chat!

Pharmidex is pleased to announce that Martin Barrett , Head of Business Development, will be attending FROM DISCOVERY TO DISTRIBUTION – Making Pharmaceuticals 2026 on 21–22 April 2026 at the Coventry Building Society Arena, UK. Martin looks forward to meeting pharma innovators, formulation scientists, manufacturing leaders and strategic partners to discuss drug discovery, development, translational science, and end-to-end pharmaceutical solutions. If you’re attending, feel free to stop by for a chat and explore how Pharmidex can support your programmes from discovery through development.